Caifeng Shi

机构：Second Affiliated Hospital of Nanjing Medical University · ORCID：0009-0001-2797-8872

发表论文 17 篇 · 总被引 194 次 · h-index 6

代表论文

• UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury (2020 · Cell Death and Disease · 被引 55)
• GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 36)
• CPT1α maintains phenotype of tubules via mitochondrial respiration during kidney injury and repair (2021 · Cell Death and Disease · 被引 36)
• Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21 (2021 · Bioengineered · 被引 16)
• Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication (2023 · Acta Diabetologica · 被引 15)
• PPARα/δ dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells (2024 · Biochemical Pharmacology · 被引 12)